Literature DB >> 23549400

Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination.

Mélanie Drolet1, Marie-Claude Boily, Christina Greenaway, Shelley L Deeks, Caty Blanchette, Jean-François Laprise, Marc Brisson.   

Abstract

BACKGROUND: Papanicolaou smear screening has significantly reduced cervical cancer morbidity and mortality. However, inequalities still persist across different socioeconomic status (SES) groups. These inequalities have been associated with differential participation in screening. However, even with equal participation to screening, some women may still have greater risk of cervical cancer because of sexual behavior. We aim to identify the sociodemographic characteristics of women who reported greater sexual activity and/or screening underuse.
METHODS: We used data from (i) the Canadian Community Health Survey-2005, a population-based survey of 130,000 Canadians, and (ii) a multicenter study including 952 women screened for cervical cancer.
RESULTS: Aboriginals and women with lower SES reported greater sexual activity and lower screening participation, which may produce synergetic effects toward higher cervical cancer risk. Women who did not complete high school and aboriginals were, respectively, 3.6 and 2.5 times more likely to report sexual debut before 15 years old compared with women with university degree and Caucasians. Women who did not complete high school were 2.2 times more likely to have never been screened compared with women with university degree. East and South Asian women were, respectively, 4.3 and 3.1 times more likely to have never been screened than Canadian-born women but reported lower levels of sexual activity and were adherent to screening guidelines when screened at least once.
CONCLUSIONS: The success of human papillomavirus vaccination at reducing cervical cancer and inequalities will depend on achieving high coverage among high-risk subpopulations. IMPACT: These groups must be monitored closely, and if need be, targeted for additional interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23549400     DOI: 10.1158/1055-9965.EPI-12-1173

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

1.  Assortativity and Mixing by Sexual Behaviors and Sociodemographic Characteristics in Young Adult Heterosexual Dating Partnerships.

Authors:  Talía Malagón; Ann Burchell; Mariam El-Zein; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  Sex Transm Dis       Date:  2017-06       Impact factor: 2.830

2.  Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.

Authors:  Kristina R Dahlstrom; Diana Bell; Duncan Hanby; Guojun Li; Li-E Wang; Qingyi Wei; Michelle D Williams; Erich M Sturgis
Journal:  Oral Oncol       Date:  2015-06-26       Impact factor: 5.337

3.  Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.

Authors:  Mélanie Drolet; Élodie Bénard; Norma Pérez; Marc Brisson
Journal:  Lancet       Date:  2019-06-26       Impact factor: 79.321

4.  Sociodemographic characteristics of women with invasive cervical cancer in British Columbia, 2004-2013: a descriptive study.

Authors:  Jonathan Simkin; Laurie Smith; Dirk van Niekerk; Hannah Caird; Tania Dearden; Kimberly van der Hoek; Nadine R Caron; Ryan R Woods; Stuart Peacock; Gina Ogilvie
Journal:  CMAJ Open       Date:  2021-04-22

5.  Effects of immigrant status on Emergency Room (ER) utilisation by children under age one: a population-based study in the province of Reggio Emilia (Italy).

Authors:  Paola Ballotari; Stefania D'Angelo; Laura Bonvicini; Serena Broccoli; Nicola Caranci; Silvia Candela; Paolo Giorgi Rossi
Journal:  BMC Health Serv Res       Date:  2013-11-01       Impact factor: 2.655

6.  Screening of cervical cancer: barriers and facilitators.

Authors:  Saurabh R Shrivastava; Prateek S Shrivastava; Jegadeesh Ramasamy
Journal:  Iran J Cancer Prev       Date:  2013

Review 7.  Current Cervical Carcinoma Screening Guidelines.

Authors:  Megan J Schlichte; Jacqueline Guidry
Journal:  J Clin Med       Date:  2015-05-07       Impact factor: 4.241

8.  Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?

Authors:  Natalie Klag; Adam C Walter; Kristen M Sheely; Kelly J Manahan; John P Geisler
Journal:  Clinicoecon Outcomes Res       Date:  2016-06-21

9.  Adherence to cervical cancer screening varies by human papillomavirus vaccination status in a high-risk population.

Authors:  Christopher A Paynter; Benjamin J Van Treeck; Inge Verdenius; Agnes W Y Lau; Twinkle Dhawan; Kayla A Lash; Elizabeth A Bergamini; Chiazotam N Ekekezie; Amna M Hilal; Kristen N James; Sadie Alongi; Sean M Harper; Aaron J Bonham; Kathy B Baumgartner; Richard N Baumgartner; Diane M Harper
Journal:  Prev Med Rep       Date:  2015-07-31

Review 10.  Human Papillomavirus Vaccination Uptake in Canada: A Systematic Review and Meta-analysis.

Authors:  Yelena Bird; Olatunji Obidiya; Razi Mahmood; Chijioke Nwankwo; John Moraros
Journal:  Int J Prev Med       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.